A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.17
C 33.00
GOOG 606.39
BAC 8.09
RIMM 15.59

Recently Added

CPIC 1.16
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.72

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.16
NBTH 12.50
IDVC 0.35
4.94 -0.06 (-1.21%) SNTS

Click Here to Receive Instant E-mail and RSS Alerts


Trade SNTS now with

Stock Details

Last Trade:4.94 Change:-0.06 (-1.21%) Prev Close:5.00 Open: 4.95 Days Range:4.90 – 4.97 52 Week Range: 2.40 - 5.10 Volume:70222 P/E: 494.00
EPS:0.01





Recent Blog Posts

Blog Posts on 12/29/11 at 4:09pm
8 Healthcare Stocks With High P/E Ratios
Blog Posts on 12/29/11 at 4:09pm
8 Healthcare Stocks With Unusually High P/E Ratios
Blog Posts on 12/22/11 at 12:30pm
Santarus' CEO Discusses Business Update Conference Call Transcript
Blog Posts on 12/02/11 at 11:58am
Santarus' CEO Discusses at Lazard Capital Markets 8th Annual Healthcare - Conference Call Transcript
Blog Posts on 10/14/11 at 11:22am
What To Do With Depomed Now
Blog Posts on 10/03/11 at 1:40pm
Santarus Plans NDA Filing On Key New Drug
Blog Posts on 09/20/11 at 7:08pm
Santarus' CEO Discusses UBS Global Life Sciences Conference Call Transcript
Blog Posts on 09/16/11 at 2:16pm
Santarus: Weighing A Promising Pipeline Against Patent Challenges
Blog Posts on 09/08/11 at 3:32pm
Key Companies And Products In The Market To Treat The Orphan Disease Hereditary Angioedema
Blog Posts on 08/03/11 at 11:29pm
Santarus CEO Discusses Q2 2011 Results - Earnings Call Transcript
Blog Posts on 05/27/11 at 10:19am
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
Blog Posts on 03/23/11 at 3:26pm
Despite Abbott Parting With Gralise, Depomed's Future Looks Bright
Blog Posts on 03/03/11 at 11:28pm
Santarus Management Discusses Q4 2010 Results - Earnings Call Transcript
Blog Posts on 01/07/11 at 7:56pm
Most Volatile Stocks on Earnings Report Days
Blog Posts on 11/09/10 at 9:31am
Santarus' Q3 Loss: The Rough Path to Recovery
Blog Posts on 10/21/10 at 5:53am
Chart of the Week: Santarus
Blog Posts on 10/20/10 at 11:12am
Looking Into Pharmas
Blog Posts on 10/06/10 at 8:38am
Healthcare Headlines: Santarus Rallies, Amgen Announces Results
Blog Posts on 09/26/10 at 5:07am
Santarus: Building a New Company on Zegerid’s Ashes
Blog Posts on 09/21/10 at 8:50am
Santarus: A Stock With Potential to Run
Blog Posts on 09/10/10 at 12:19pm
Are Unemployment Claims as Bullish as They Seem?
Blog Posts on 05/07/10 at 3:34am
Santarus Inc. Q1 2010 Earnings Call Transcript
Blog Posts on 04/18/10 at 2:46pm
Pulse Check: Pharmaceuticals Roundup
Blog Posts on 04/06/10 at 4:45pm
Santarus' Over the Counter Drug Launched
Blog Posts on 03/07/10 at 7:02am
Santarus Beats on Higher Revenues
Blog Posts on 01/04/10 at 3:37am
Biotech’s 2009 Stealth Small Cap Rally
Blog Posts on 11/20/09 at 4:05am
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
Blog Posts on 11/16/09 at 10:33am
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
Blog Posts on 08/02/09 at 5:06am
Extreme FDA Trades: 30 Stocks Under 5 Bucks
Blog Posts on 06/28/09 at 4:50am
FDA Extreme Trades: 16 Stocks Under 5 Bucks